Phenytoin prophylaxis of cardiotoxicity in experimental amitriptyline poisoning

M. Callaham, H. Schumaker, P. Pentel

Research output: Contribution to journalArticle

49 Scopus citations

Abstract

Tricyclic antidepressants (TCA) are drugs with Type IA antiarrhythmic properties that cause severe cardiac conduction blocks, hypotension, and ventricular dysrhythmias at toxic levels. Phenytoin has been proposed as a prophylaxis and treatment of these dysrhythmias, since it is thought to improve conduction in this setting. Anesthetized dogs were given a loading dose of phenytoin, followed by constant amitriptyline infusion until death. Variables known to affect TCA toxicity, such as arterial pH, were carefully controlled. There were no significant differences between the phenytoin and control group in any physiologic parameter, including toxicity, drug levels, or dose to death. However, duration and frequency of episodes of ventricular tachycardia were dramatically increased in the phenytoin group. It is concluded that prophylactic phenytoin in this animal model provides no benefits and may in fact increase the severity of ventricular tachycardia and hypotension. In addition, it is speculated that similar adverse effects of phenytoin might be seen in other Type IA antiarrhythmics if the extremely toxic levels seen in this study with TCA were reached.

Original languageEnglish (US)
Pages (from-to)216-220
Number of pages5
JournalJournal of Pharmacology and Experimental Therapeutics
Volume245
Issue number1
StatePublished - Jan 1 1988

Fingerprint Dive into the research topics of 'Phenytoin prophylaxis of cardiotoxicity in experimental amitriptyline poisoning'. Together they form a unique fingerprint.

  • Cite this